Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Salmeterol/Fluticasone Easyhaler vs Seretide Diskus
NCT03060044Phase 1Completed
- Sponsor
- Orion Corporation
- Start
- Jul 2016
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of salmeterol and fluticasone propionate in asthma (4 arms), sponsored by Orion Corporation. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to Last Quantifiable Concentration. Started Jul 2016; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03060044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03060044.